Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
Alto Pharmacy, founded in 2015 and headquartered in San Francisco, is a digital pharmacy that offers prescription delivery, care specialist access, and insurance support. The company has revolutionized the pharmaceutical sector by rebuilding the operational model of pharmacies from the ground up, using technology to deliver an eCommerce-like experience and technology-driven solutions.
Since its inception, Alto has experienced significant growth, delivering over four million prescriptions to hundreds of thousands of patients. The company's unique delivery-first, app-based pharmacy model has helped patients save more than $190 million on medications and has driven 71% better medication adherence than the industry average on first fill. Alto boasts an impressive Net Promoter Score of 90, far surpassing the industry standard.
Alto Pharmacy has successfully raised $647.37 million in total funding across multiple rounds, with its most recent Series F round in September 2023 raising $120 million at a valuation of $800 million. This latest funding round demonstrates continued investor confidence in the company's business model and growth potential.
While there is no concrete information available regarding Alto Pharmacy's IPO prospects, the company's rapid growth, innovative approach to digital pharmacy services, and substantial funding rounds have positioned it as a significant player in the evolving healthcare technology landscape. As with any private company, the decision to go public would depend on various factors, including market conditions, company readiness, and strategic objectives.
Investors and industry observers will likely continue to monitor Alto Pharmacy's progress and any potential announcements regarding its future plans, including the possibility of an IPO. However, it's important to note that any discussions about a potential IPO remain speculative at this time.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While Alto Pharmacy's IPO prospects remain uncertain, investors interested in the digital health and pharmacy space don't have to wait. At Linqto, we offer members access to interests in promising private companies before they go public. Our platform provides opportunities to invest in potential industry leaders like Alto Pharmacy, with lower minimum investments than traditional private equity options. This allows you to diversify your portfolio and potentially benefit from the growth of innovative healthcare companies before they hit the public markets.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
